Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1976 5
1977 3
1978 7
1979 4
1980 4
1981 5
1983 6
1984 3
1985 8
1986 10
1987 1
1988 5
1989 5
1990 7
1991 4
1992 8
1993 10
1994 4
1995 5
1996 5
1997 5
1998 6
1999 11
2000 5
2001 2
2002 2
2003 10
2004 5
2005 9
2006 9
2007 5
2008 3
2009 4
2010 4
2011 2
2012 4
2013 2
2014 1
2015 6
2016 2
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Results by year

Filters applied: . Clear all
Page 1
The ARRONAX project.
Haddad F, Barbet J, Chatal JF. Haddad F, et al. Among authors: chatal jf. Curr Radiopharm. 2011 Jul;4(3):186-96. doi: 10.2174/1874471011104030186. Curr Radiopharm. 2011. PMID: 22201708 Review.
Radionuclide therapy.
Chatal JF, Hoefnagel CA. Chatal JF, et al. Lancet. 1999 Sep 11;354(9182):931-5. doi: 10.1016/S0140-6736(99)06002-X. Lancet. 1999. PMID: 10489968 Review.
Tumor immunotargeting using innovative radionuclides.
Kraeber-Bodéré F, Rousseau C, Bodet-Milin C, Mathieu C, Guérard F, Frampas E, Carlier T, Chouin N, Haddad F, Chatal JF, Faivre-Chauvet A, Chérel M, Barbet J. Kraeber-Bodéré F, et al. Among authors: chatal jf. Int J Mol Sci. 2015 Feb 11;16(2):3932-54. doi: 10.3390/ijms16023932. Int J Mol Sci. 2015. PMID: 25679452 Free PMC article. Review.
Alphatherapy, the new impetus to targeted radionuclide therapy?
Chatal JF, Kraeber-Bodéré F, Chérel M, Haddad F. Chatal JF, et al. Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1362-1363. doi: 10.1007/s00259-018-4026-z. Eur J Nucl Med Mol Imaging. 2018. PMID: 29696441 No abstract available.
Alpha particles more promising than toxins?
Barbet J, Chérel M, Chatal JF. Barbet J, et al. Among authors: chatal jf. Eur J Nucl Med Mol Imaging. 2010 May;37(5):849-50. doi: 10.1007/s00259-010-1421-5. Eur J Nucl Med Mol Imaging. 2010. PMID: 20306031 No abstract available.
Cancer radioimmunotherapy with alpha-emitting nuclides.
Couturier O, Supiot S, Degraef-Mougin M, Faivre-Chauvet A, Carlier T, Chatal JF, Davodeau F, Cherel M. Couturier O, et al. Among authors: chatal jf. Eur J Nucl Med Mol Imaging. 2005 May;32(5):601-14. doi: 10.1007/s00259-005-1803-2. Eur J Nucl Med Mol Imaging. 2005. PMID: 15841373 Review.
A pretargeting system for tumor PET imaging and radioimmunotherapy.
Kraeber-Bodéré F, Rousseau C, Bodet-Milin C, Frampas E, Faivre-Chauvet A, Rauscher A, Sharkey RM, Goldenberg DM, Chatal JF, Barbet J. Kraeber-Bodéré F, et al. Among authors: chatal jf. Front Pharmacol. 2015 Mar 31;6:54. doi: 10.3389/fphar.2015.00054. eCollection 2015. Front Pharmacol. 2015. PMID: 25873896 Free PMC article. Review.
206 results